ArticleIJU case reports2026

Complete Response to Pembrolizumab After Progression on Avelumab Maintenance in Metastatic Urothelial Carcinoma.

Fumihiro Ito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.